Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;146(6):853-856.
doi: 10.1007/s00401-023-02638-1. Epub 2023 Sep 30.

Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics

Affiliations

Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics

Ramin Rahmanzade et al. Acta Neuropathol. 2023 Dec.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
ah PPTIDwild of transitional subtype depicting areas with diffuse growth pattern and clear-cell morphology (a) and, also, rosette-forming areas with typical histology of pineocytoma (b). Although both areas showed elevated proliferation index (c and d, hotspot Ki67: 8.7%), the neurofilament protein was significantly less expressed in diffuse area (e and f). Hotspot-Ki67 was measured via QuPath in order to reduce the inter-observer variability (g). Molecular analyses revealed a wild-type KBTBD4 gene, loss of chromosome 13q (h) and a DNA methylation class distinct from PPTID-A and -B. i Unsupervised DNA methylation-based t-SNE showed that PPTIDwt are epigenetically more similar to pineocytoma than PPTIDmut. jl Kaplan–Meier curves by log-rank test. KBTBD4 insertions (j, p value 0.03) and hotspot Ki67 greater than or equal to 8% (k, p value 0.02) were significantly associated with worse progression-free survival (PFS). The 2007 WHO grading system (l, p value 0.8) failed to correlate with the PFS

References

    1. Fauchon F, Jouvet A, Paquis P, Saint-Pierre G, Mottolese C, Ben Hassel M, et al. Parenchymal pineal tumors: a clinicopathological study of 76 cases. Int J Radiat Oncol Biol Phys. 2000;46(4):959–968. doi: 10.1016/s0360-3016(99)00389-2. - DOI - PubMed
    1. Fèvre-Montange M, Vasiljevic A, Frappaz D, Champier J, Szathmari A, Aubriot Lorton MH, et al. Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study. Neuropathol Appl Neurobiol. 2012;38(1):87–94. doi: 10.1111/j.1365-2990.2011.01202.x. - DOI - PubMed
    1. Jouvet A, Saint-Pierre G, Fauchon F, Privat K, Bouffet E, Ruchoux MM, et al. Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 cases. Brain Pathol. 2000;10(1):49–60. doi: 10.1111/j.1750-3639.2000.tb00242.x. - DOI - PMC - PubMed
    1. Kerezoudis P, Yolcu YU, Laack NN, Ruff MW, Khatua S, Daniels DJ, et al. Survival and associated predictors for patients with pineoblastoma or pineal parenchymal tumors of intermediate differentiation older than 3 years: insights from the National Cancer Database. Neurooncol Adv. 2022;4(1):vdac057. doi: 10.1093/noajnl/vdac057. - DOI - PMC - PubMed
    1. Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS, et al. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathol. 2019;137(5):851–854. doi: 10.1007/s00401-019-01990-5. - DOI - PMC - PubMed

Publication types